CGP 79807
Alternative Names: CGP-79807Latest Information Update: 03 Apr 2003
At a glance
- Originator Novartis
- Class Antineoplastics; Benzonitrile
- Mechanism of Action CDC2 protein kinase inhibitors; Cyclin-dependent kinase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 03 Apr 2003 No development reported - Preclinical for Cancer in Switzerland (unspecified route)
- 20 Sep 2000 New profile
- 20 Sep 2000 Preclinical development for Cancer in Switzerland (Unknown route)